A once-daily antibiotic regimen for group A β-hemolytic streptococcal pharyngitis (GABHS) could improve compliance and be effective in the prevention of rheumatic fever, a dangerous complication of untreated or poorly treated GABHS. Amoxicillin is ideal for once-daily dosing due to its low cost. Azithromycin, cefadroxil, ceftibuten, cefixime and extended release amoxicillin are also FDA approved to treat GABHS once daily; however, even when taken for short courses, these antibiotics are more expensive compared with a oncedaily dosing of conventional amoxicillin for 10 days. The American Heart Association recently recommended once-daily amoxicillin dosing when treating GABHS, and amoxicillin has been proven to be effective when dosed once daily, with no obvious disadvantage compared with twice-daily dosing or with conventional penicillin treatment 3 to 4 times daily.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3042262PMC

Publication Analysis

Top Keywords

once-daily amoxicillin
8
gabhs amoxicillin
8
dosing conventional
8
amoxicillin
5
once-daily
4
amoxicillin pharyngitis
4
pharyngitis once-daily
4
once-daily antibiotic
4
antibiotic regimen
4
regimen group
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!